NCT04023591

Brief Summary

Current treatment strategies of acute cervical spinal cord injuries remain limited. Treatment options that provide meaningful improvements in patient quality of like and long-term functional independence will provide a significant public health impact. Specific aim: Measure the efficacy of nerve transfer surgery in the treatment of patients with complete spinal cord injuries with no hand function. Optimize the efficiency of nerve transfer surgery by evaluating patient outcomes in relation to patient selection and quality of life and functional independence.

Trial Health

78
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
7mo left

Started Apr 2020

Longer than P75 for all trials

Geographic Reach
2 countries

9 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress91%
Apr 2020Dec 2026

First Submitted

Initial submission to the registry

July 11, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 17, 2019

Completed
9 months until next milestone

Study Start

First participant enrolled

April 13, 2020

Completed
5.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Expected
Last Updated

September 9, 2025

Status Verified

September 1, 2025

Enrollment Period

5.9 years

First QC Date

July 11, 2019

Last Update Submit

September 2, 2025

Conditions

Keywords

tetraplegiaspinal cord injuryquadriplegianerve transfer

Outcome Measures

Primary Outcomes (2)

  • Manual Motor Testing

    Change from baseline testing strength of upper extremities at 48 months post-operatively

    48 months

  • Handheld Dynamometry

    Change from baseline grip strength at 48 months post-operatively

    48 months

Secondary Outcomes (7)

  • Change in Disabilities of Arm, Shoulder and Hand (DASH) scores

    48 months

  • Change in Spinal Cord Injury Quality of Life (SCIQOL) scores

    48 months

  • Rates of Intra-operative and post-operative complications

    48 months

  • Hand Function, measured by the GRASSP test

    48 months

  • Changes in the Graded Redefined Assessment of Strength, Sensation and Prehension scores (GRASSP)

    48 months

  • +2 more secondary outcomes

Study Arms (1)

Surgery

Surgery/ Occupational Therapy

Procedure: Surgery/Occupational Therapy

Interventions

Surgery based on function and injury/ Occupational therapy for 48 months post-surgery

Surgery

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants with a traumatic cervical spine injury with little to no use of his/her arms/hands.

You may qualify if:

  • Age 18-65, inclusive
  • At least 3 months of non-operative rehab therapy
  • Mentally and physically willing and able to comply with evaluations
  • Less than 36 months post-injury
  • Stable ASIA scores with no evidence of functional improvement in motor or sensory examination for at least 3 months
  • ASIA A or B determined by the International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI)
  • EMG/NCS verifies intact innervation (normal CMAPs) to the paralyzed target muscles below the level of injury
  • Functional electrical stimulation (FES) will be performed. Subject must have clinically normal MRC grade 5/5 donor (axonal) function
  • Injury Level C4-C8

You may not qualify if:

  • Active infection at the operative site or systemic infection
  • Any return or ongoing clinical recovery of distal motor function
  • Mentally or physically compromised that will prevent them from complying with evaluations.
  • Immunologically suppressed
  • Currently undergoing long-term steroid therapy
  • Active malignancy
  • Pregnant
  • Significant joint contractures and/or limitations in passive range of motion in the arm or hand, per treating surgeon's discretion
  • Lack of appropriate social support and/or infrastructure to commit to scheduled follow-up visits.
  • Patients who are planning on undergoing a tendon transfer during the study period or who have had a tendon transfer in the past.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (9)

Stanford University

Stanford, California, 94305, United States

Location

University of Miami

Miami, Florida, 33136, United States

Location

University of Michigan

Ann Arbor, Michigan, 48109, United States

Location

Washington University

St Louis, Missouri, 63110, United States

Location

University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

Location

Houston Methodist

Houston, Texas, 77030, United States

Location

University of Utah

Salt Lake City, Utah, 84132, United States

Location

Alberta Health Services - Foothills Medical Center

Calgary, Alberta, T2N 2T9, Canada

Location

University of Alberta

Edmonton, Alberta, T6G 2E1, Canada

Location

Related Links

MeSH Terms

Conditions

QuadriplegiaSpinal Cord Injuries

Interventions

Surgical Procedures, OperativeOccupational Therapy

Condition Hierarchy (Ancestors)

ParalysisNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsSpinal Cord DiseasesCentral Nervous System DiseasesTrauma, Nervous SystemWounds and Injuries

Intervention Hierarchy (Ancestors)

RehabilitationAftercareContinuity of Patient CarePatient CareTherapeutics

Study Officials

  • Wilson Z Ray, MD

    Washington University School of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 11, 2019

First Posted

July 17, 2019

Study Start

April 13, 2020

Primary Completion

March 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

September 9, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

No plan to share individual participant data. Only aggregate data will be published.

Locations